ArticleAmerican journal of cancer research2021

Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.

Allison Staley et al.PubMed ↗Full text ↗

No numbers read from the abstract.